COVID-19 Diagnostic Testing: Lessons Learned for Innovative Product Development During A Public Health Emergency.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 3, p. 52, doi. 10.5912/jcb944
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2020 AND VI 25 AND IP 3
Results: 5
1
2
Biopharma licensing and M&A trends in the 21st-century landscape.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 3, p. 37, doi. 10.5912/jcb943
- By:
- Publication type:
- Article
3
Could COVID-19 Cause 'Biopharming' to Bloom?
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 3, p. 34, doi. 10.5912/jcb941
- By:
- Publication type:
- Article
4
The Spreading Cancer of Counterfeit Drugs: Pharmaceutical Fakery Metastasizes from Lifestyle to Lifesaving Medicines.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 3, p. 20, doi. 10.5912/jcb940
- By:
- Publication type:
- Article
5
A Critical Review On Nano-Food Packaging and Its Applications.
- Published in:
- Journal of Commercial Biotechnology, 2020, v. 25, n. 3, p. 3, doi. 10.5912/jcb882
- By:
- Publication type:
- Article